Drug General Information
Drug ID
D0A4DR
Former ID
DNC000184
Drug Name
Alpha-methyl-alpha-phenylsuccinimide (MPS)
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535283]
Structure
Download
2D MOL

3D MOL

Formula
C11H11NO2
Canonical SMILES
CC1(CC(=O)NC1=O)C2=CC=CC=C2
InChI
1S/C11H11NO2/c1-11(7-9(13)12-10(11)14)8-5-3-2-4-6-8/h2-6H,7H2,1H3,(H,12,13,14)
InChIKey
UDESUGJZUFALAM-UHFFFAOYSA-N
CAS Number
CAS 1497-17-2
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Voltage-dependent T-type calcium channel alpha-1G subunit Target Info Blocker [535283]
KEGG Pathway MAPK signaling pathway
Calcium signaling pathway
Circadian entrainment
Type II diabetes mellitus
PANTHER Pathway Endogenous cannabinoid signaling
GABA-B receptor II signaling
Nicotine pharmacodynamics pathway
Pathway Interaction Database Regulation of nuclear beta catenin signaling and target gene transcription
PathWhiz Pathway Muscle/Heart Contraction
Reactome NCAM1 interactions
WikiPathways NCAM signaling for neurite out-growth
Nicotine Activity on Chromaffin Cells
References
Ref 535283Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol Pharmacol. 2001 Nov;60(5):1121-32.
Ref 535283Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol Pharmacol. 2001 Nov;60(5):1121-32.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.